Ishara Investments LP
Filing Date
Global Rank
#5,248
/ 8,232
▲ 671
Top Industry
Biotechnology
94.4%
3Y Alpha vs SPY
-27.2%
Period ended 2 months ago
Filed May 15, 2026 · 30d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+1.0%
SPY
+9.1%
Annualised alpha
-27.2%
Max drawdown
−13.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
36 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
13.1%
−0.5 pts
Top 5
35.6%
−3.0 pts
Top 10
54.0%
−2.5 pts
HHI
467
Diversified−22
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $105,625,564 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VSTM | Verastem, Inc. | +550,000 | 820,000 | $4,346,000 | |
| XERS | Xeris Biopharma Holdings, Inc. | +225,000 | 1,025,000 | $5,945,000 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +124,250 | 174,250 | $3,650,537 | |
| IMTX | Immatics N.V. | +73,750 | 153,750 | $1,512,900 | |
| LXRX | Lexicon Pharmaceuticals, Inc. | +22,000 | 902,000 | $1,407,120 | |
| GMAB | Genmab A/S | +12,000 | 82,000 | $2,200,060 | |
| FOLD | AMICUS THERAPEUTICS, INC. | +9,000 | 369,000 | $5,335,740 | |
| PCVX | Vaxcyte, Inc. | +7,400 | 57,400 | $3,335,514 | |
| BEAM | Beam Therapeutics Inc. | +7,400 | 57,400 | $1,367,842 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +6,900 | 36,900 | $1,181,169 | |
| PRAX | Praxis Precision Medicines, Inc. | +3,050 | 43,050 | $13,870,279 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ANNX | Annexon, Inc. | −575,750 | 174,250 | $965,345 | |
| SLN | Silence Therapeutics plc | −99,500 | 140,500 | $740,435 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | −90,000 | 1,230,000 | $2,878,200 | |
| ORIC | Oric Pharmaceuticals, Inc. | −57,500 | 102,500 | $1,298,675 | |
| ACAD | Acadia Pharmaceuticals Inc | −37,000 | 123,000 | $2,737,980 | |
| PTCT | Ptc Therapeutics, Inc. | −25,750 | 10,250 | $698,332 | |
| BMRN | Biomarin Pharmaceutical Inc | −18,000 | 82,000 | $4,632,180 | |
| EWTX | Edgewise Therapeutics, Inc. | −8,800 | 49,200 | $1,549,800 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
17 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | 41,000 | $6,929,820 | |
| KALV | KalVista Pharmaceuticals, Inc. | 276,750 | $5,570,977 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 55,350 | $3,470,445 | |
| VERA | Vera Therapeutics, Inc. | 82,000 | $3,298,860 | |
| TVTX | Travere Therapeutics, Inc. | 110,700 | $3,288,897 | |
| MLTX | MoonLake Immunotherapeutics | 174,250 | $3,248,020 | |
| SRRK | Scholar Rock Holding Corp | 57,400 | $2,821,784 | |
| ARDX | Ardelyx, Inc. | 451,000 | $2,701,490 | |
| MLYS | Mineralys Therapeutics, Inc. | 82,000 | $2,221,380 | |
| DBVT | DBV Technologies S.A. | 102,500 | $2,141,225 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 82,000 | $2,030,320 | |
| SION | Sionna Therapeutics, Inc. | 49,200 | $1,972,428 | |
| CTNM | Contineum Therapeutics, Inc. | 142,000 | $1,854,520 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5,125 | $1,695,708 | |
| LGND | Ligand Pharmaceuticals Inc | 8,200 | $1,637,130 | |
| IDYA | IDEAYA Biosciences, Inc. | 24,600 | $819,672 | |
| GOSS | Gossamer Bio, Inc. | 820,000 | $269,780 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
19 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NUVB | Nuvation Bio Inc. | 400,000 | $3,584,000 | |
| BBIO | BridgeBio Pharma, Inc. | 36,000 | $2,753,640 | |
| UTHR | UNITED THERAPEUTICS Corp | 5,500 | $2,679,875 | |
| BCRX | Biocryst Pharmaceuticals Inc | 300,000 | $2,340,000 | |
| SNDX | Syndax Pharmaceuticals Inc | 100,000 | $2,101,000 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 24,000 | $1,965,120 | |
| INSM | INSMED Inc | 10,000 | $1,740,400 | |
| CORT | Corcept Therapeutics Inc | 44,000 | $1,531,200 | |
| APLS | Apellis Pharmaceuticals, Inc. | 50,000 | $1,256,000 | |
| DNLI | Denali Therapeutics Inc. | 70,000 | $1,155,700 | |
| ASND | Ascendis Pharma A/S | 5,000 | $1,066,200 | |
| BHVN | Biohaven Ltd. | 88,000 | $993,520 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 24,000 | $989,040 | |
| APOG | Apogee Enterprises, Inc. | 25,000 | $910,250 | |
| NKTR | Nektar Therapeutics | 20,000 | $845,600 | |
| AGIO | Agios Pharmaceuticals, Inc. | 30,000 | $816,600 | |
| IMVT | Immunovant, Inc. | 30,000 | $762,600 | |
| OLMA | Olema Pharmaceuticals, Inc. | 30,000 | $750,000 | |
| ARQT | Arcutis Biotherapeutics, Inc. | 12,000 | $348,480 | |
| No positions match the current search. | ||||
36 positions ·
$105,625,564 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 43,050 | $13,870,279 | 13.13% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
NEW | 41,000 | $6,929,820 | 6.56% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
Added | 1,025,000 | $5,945,000 | 5.63% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
NEW | 276,750 | $5,570,977 | 5.27% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
Added | 369,000 | $5,335,740 | 5.05% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 82,000 | $4,632,180 | 4.39% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Added | 820,000 | $4,346,000 | 4.11% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 174,250 | $3,650,537 | 3.46% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
NEW | 55,350 | $3,470,445 | 3.29% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 57,400 | $3,335,514 | 3.16% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
NEW | 82,000 | $3,298,860 | 3.12% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
NEW | 110,700 | $3,288,897 | 3.11% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 174,250 | $3,248,020 | 3.08% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,230,000 | $2,878,200 | 2.72% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
NEW | 57,400 | $2,821,784 | 2.67% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Reduced | 123,000 | $2,737,980 | 2.59% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
NEW | 451,000 | $2,701,490 | 2.56% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
NEW | 82,000 | $2,221,380 | 2.10% | |
| GMAB |
Genmab A/S
Healthcare
|
Added | 82,000 | $2,200,060 | 2.08% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
NEW | 102,500 | $2,141,225 | 2.03% | |
| CPRX |
Catalyst Pharmaceuticals, Inc.
Healthcare
|
NEW | 82,000 | $2,030,320 | 1.92% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
NEW | 49,200 | $1,972,428 | 1.87% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
NEW | 142,000 | $1,854,520 | 1.76% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
NEW | 5,125 | $1,695,708 | 1.61% | |
| LGND |
Ligand Pharmaceuticals Inc
Healthcare
|
NEW | 8,200 | $1,637,130 | 1.55% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 49,200 | $1,549,800 | 1.47% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 153,750 | $1,512,900 | 1.43% | |
| LXRX |
Lexicon Pharmaceuticals, Inc.
Healthcare
|
Added | 902,000 | $1,407,120 | 1.33% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Added | 57,400 | $1,367,842 | 1.29% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 102,500 | $1,298,675 | 1.23% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Added | 36,900 | $1,181,169 | 1.12% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Reduced | 174,250 | $965,345 | 0.91% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
NEW | 24,600 | $819,672 | 0.78% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Reduced | 140,500 | $740,435 | 0.70% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Reduced | 10,250 | $698,332 | 0.66% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
NEW | 820,000 | $269,780 | 0.26% |